2024 年度公司及子公司信贷方案 根据浙江中欣氟材股份有限公司（以下简称"公司"）2024 年度的经营计划 和融资需求，公司及控股子公司拟向合作银行申请总额不超过 20 亿元人民币（或 等值外币）的综合授信额度，授权期限为一年，自 2023 年年度股东大会审议通 过之日起生效。综合授信用于办理流动资金贷款、项目资金贷款、银行承兑汇票、 国内信用证、应收账款保理、商业票据贴现、银行保函等各种贷款及贸易融资业 务。 浙江中欣氟材股份有限公司董事会 2024 年 4 月 12 日 上述授信额度不等于公司的融资金额，最终以银行实际审批的授信额度为准。 上述授信额度在授权期限内可循环使用。在此额度范围内，银行授信业务及与之 配套的担保、抵押事项，在不超过上述授信和融资额度的前提下，无需再逐项提 请董事会或股东大会审批和披露。 公司董事会提请股东大会授权董事长或董事长指定代理人代表公司及控股 子公司根据实际情况在上述授信额度内，办理公司及控股子公司的融资事宜，签 署与授信（包括但不限于授信、借款、担保、抵押、融资等）相关的合同、协议、 凭证等各项法律文件，并可根据融资成本及各银行资信状况具体选择商业银行。 ...

证券代码：002915 证券简称：中欣氟材 公告编号：2024-029 浙江中欣氟材股份有限公司 关于会计政策变更的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示： 浙江中欣氟材股份有限公司（以下简称"公司"）根据中华人民共和国财政部 （以下简称"财政部"）颁布的《企业会计准则解释第 17 号》（财会〔2023〕21 号，以下简称"《解释第 17 号》"）的要求变更会计政策，不会对公司当期的财 务状况、经营成果和现金流量产生重大影响。 浙江中欣氟材股份有限公司于 2024 年 4 月 12 日召开的第六届董事会第十四 次会议和第六届监事会第十二次会议审议通过了《关于会计政策变更的议案》， 该议案无需提交公司股东大会审议批准。现将相关事项公告如下： 一、本次会计政策变更概述 （一）会计政策变更的原因及适用日期 财政部于 2023 年 10 月 25 日公布了《解释第 17 号》，"关于售后租回交易 的会计处理"内容自 2024 年 1 月 1 日起施行。 由于上述会计准则解释的发布，公司需对会计政策进行相应变更，并按以上 文件规定的生效日期开 ...

证券代码：002915 证券简称：中欣氟材 公告编号：2024-023 浙江中欣氟材股份有限公司 2023年度募集资金存放与使用情况专项报告 本公司及董事会全体成员保证信息披露的真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 根据中国证券监督管理委员会《上市公司监管指引第 2 号——上市公司募集 资金管理和使用的监管要求（2022 年修订）》（证监会公告〔2022〕15 号）、 《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》以 及《深圳证券交易所上市公司自律监管指南第 2 号——公告格式》的相关规定， 本公司就 2023 年度募集资金存放与使用情况作如下专项报告： 一、募集资金基本情况 （一）实际募集资金金额、资金到位时间 经中国证券监督管理委员会《关于核准浙江中欣氟材股份有限公司非公开发 行股票的批复》（证监许可[2021]1172 号）的核准，公司非公开发行 A 股股票 25,914,956.00 股，发行价格每股 17.05 元，共募集人民币 441,849,999.80 元。 上述募集资金由主承销商申万宏源证券承销保荐有限责任公司于 2021 年 8 月 4 日在扣 ...

2023 年度董事会工作报告 浙江中欣氟材股份有限公司（以下简称"公司"）董事会由 11 名董事组成， 董事会严格按照《中华人民共和国公司法》《中华人民共和国证券法》《深圳证 券交易所股票上市规则》等法律法规及《浙江中欣氟材股份有限公司章程》《浙 江中欣氟材股份有限公司股东大会议事规则》《浙江中欣氟材股份有限公司董事 会议事规则》等公司制度的规定，切实履行股东大会赋予的董事会职责，严格执 行股东大会各项决议，积极推进董事会各项决议的实施，不断规范公司法人治理 结构，确保董事会科学决策和规范运作。 现将公司董事会 2023 年度工作情况汇报如下： 一、2023 年度公司经营情况分析 1、基本情况 2023 年度，在面临新形势下经济的不稳定性、愈加严格的安环核查压力、 下游市场需求下滑和行业内卷加剧等众多外部环境不利因素的影响，在充满挑战 的外部环境下，公司全体员工持续发扬"艰苦奋斗、坚韧拼搏"的精神，坚持稳中 求进，并力争稳中快进，坚定不移围绕年初制定的三年发展战略定位，扎实推进 全产业链项目建设的战略布局。 这一年，公司锁定中长期目标，通过合理把握经营节奏，适度投资先进产业， 不断优化市场布局、持续技术创新突 ...

浙江中欣氟材股份有限公司 关于会计师事务所2023年度履职情况评估报告 浙江中欣氟材股份有限公司（以下简称"公司"）聘请立信会计师事务所（特 殊普通合伙）（以下简称"立信"）作为公司 2023 年度年报审计机构。根据财政 部、国资委及证监会颁布的《国有企业、上市公司选聘会计师事务所管理办法》， 公司对立信 2023 年审计过程中的履职情况进行评估。经评估，公司认为立信资 质等方面合规有效，履职保持独立性，勤勉尽责，公允表达意见，具体情况如下： 一、资质条件 1、基本信息 立信会计师事务所（特殊普通合伙）（以下简称"立信"）由我国会计泰斗潘 序伦博士于 1927 年在上海创建，1986 年复办，2010 年成为全国首家完成改制的 特殊普通合伙制会计师事务所，注册地址为上海市，首席合伙人为朱建弟先生。 立信是国际会计网络 BDO 的成员所，长期从事证券服务业务，新证券法实施前 具有证券、期货业务许可证，具有 H 股审计资格，并已向美国公众公司会计监 督委员会（PCAOB）注册登记。 截至 2023 年末，立信拥有合伙人 278 名、注册会计师 2,533 名、从业人员 总数 10,730 名，签署过证券服务业务审 ...

苏为科：男，1961 年 2 月出生，中国国籍，无境外永久居留权，浙江大学 有机化学专业博士、博士生导师、浙江省特级专家。浙江工业大学教授、绿色制 药技术与装备教育部重点实验室主任、浙江省制药重中之重学科负责人、浙江省 新药创制科技服务平台负责人，一直从事药学相关的教学及科研工作，曾任本公 司独立董事、兄弟科技股份有限公司独立董事、浙江花园生物高科股份有限公司 独立董事、浙江金诺源药业有限公司董事、浙江奭诺生物技术有限公司董事、浙 江海翔药业股份有限公司独立董事，现任浙江省长三角生物医药产业技术研究园 法定代表人、德清天诺生物医药科技有限公司执行董事兼总经理、浙江省化工学 会常务理事、浙江省药学会常务理事、浙江扬帆新材料股份有限公司独立董事、 奥锐特药业股份有限公司独立董事、浙江和泽医药科技股份有限公司（非上市） 独立董事、浙江野风药业股份有限公司（非上市）独立董事；自 2022 年 8 月开 始担任本公司独立董事。 （二）是否存在影响独立性的情况说明 浙江中欣氟材股份有限公司 独立董事 2023 年度述职报告 本人作为浙江中欣氟材股份有限公司（以下简称"公司"或"本公司"）的独立 董事，我在任职期间严格按照 ...

证券代码：002915 证券简称：中欣氟材 公告编号：2024-019 浙江中欣氟材股份有限公司 第六届监事会第十二次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 浙江中欣氟材股份有限公司（以下简称"公司"）第六届监事会第十二次会议 于 2024 年 4 月 12 日在杭州湾上虞经济技术开发区经十三路五号浙江中欣氟材股 份有限公司研发中心一楼视频会议室以现场表决方式召开。会议通知以书面、邮 件或电话方式于 2024 年 3 月 26 日向全体监事发出。应出席监事 3 名，实际出席 监事 3 名。 会议由监事会主席俞伟樑先生召集并主持。本次会议的通知、召集和召开符 合《中华人民共和国公司法》（以下简称"《公司法》"）和《浙江中欣氟材股份 有限公司章程》（以下简称"《公司章程》"）的规定，会议决议合法有效。 二、监事会会议审议情况 （一）审议通过了《2023 年年度报告及其摘要》 公司监事会认为董事会编制和审核《浙江中欣氟材股份有限公司 2023 年年 度报告及其摘要》的程序符合法律、行政法规和中国证监会的规定，报告内容真 ...

本报告依据中国资产评估准则编制 浙江中欣氟材股份有限公司拟进行商誉减值测试涉及的包含商 誉的江西中欣埃克盛新材料有限公司资产组可收回金额项目 资产评估报告 浙中企华评报字(2024)第 0115 号 （共一册，第一册） 浙江中企华资产评估有限公司 二〇二四年四月十一日 | 声明 | 1 | | --- | --- | | 资产评估报告摘要 | 3 | | 资产评估报告正文 | 5 | | 一、 | 委托人、被评估单位和资产评估委托合同约定的其他资产评估报告使用人 .5 | | 二、 | 评估目的 9 | | 三、 | 评估对象和评估范围 10 | | 四、 | 价值类型 13 | | 五、 | 评估基准日 14 | | 六、 | 评估依据 14 | | 七、 | 评估方法 18 | | 八、 | 评估程序实施过程和情况 20 | | 九、 | 评估假设 22 | | 十、 | 评估结论 24 | | 十一、 | 特别事项说明 25 | | 十二、 | 资产评估报告使用限制说明 26 | | 十三、 | 资产评估报告日 27 | | 资产评估报告附件 | 28 | 浙江中欣氟材股份有限公司拟进行商誉减值测试涉及 ...

证券代码：002915 证券简称：中欣氟材 公告编号：2024-033 二、拟设立全资子公司的基本情况 浙江中欣氟材股份有限公司 关于投资设立全资子公司的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、对外投资概述 （一）对外投资的基本情况 根据浙江中欣氟材股份有限公司（以下简称"中欣氟材"或"公司"）发展战略 及实际经营需要，公司拟以自有资金人民币 8,000 万元投资设立杭州中欣氟材发 展有限公司（暂定名，以实际工商注册名称为准）。 （二）董事会审议情况 2024 年 4 月 12 日，公司召开第六届董事会第十四次会议审议通过了《关于 投资设立全资子公司的议案》。根据《公司章程》及公司《对外投资管理制度》 的规定，本次对外投资事项属于董事会审批权限，无需提交公司股东大会审议。 （三）本次对外投资不构成关联交易，亦不属于《上市公司重大资产重组管 理办法》规定的重大资产重组。 1、公司名称：杭州中欣氟材发展有限公司 2、公司类型：有限责任公司 3、注册资本：人民币 8,000 万元 4、法定代表人：王超 5、注册地址：杭州市下城区西湖文化广场 19 ...

Environmental Compliance and Management - The company has completed the rectification of issues identified in the special governance action as required by the Zhejiang Securities Regulatory Bureau[1]. - The company strictly adheres to various environmental protection laws and standards, including the Comprehensive Emission Standard of Air Pollutants (GB16297-1996) and the Wastewater Comprehensive Discharge Standard (GB8978-1996)[5]. - The company obtained the Pollutant Discharge Permit for the West Plant on August 17, 2023, valid until August 16, 2028, and for the East Plant on September 14, 2023, valid until September 13, 2028[8]. - The total wastewater discharge for the company is 24.07144 tons, with a chemical oxygen demand concentration of ≤500 mg/L, complying with the GB8978-1996 standard[12]. - The company reported a total of 7.934137 tons of VOCs emissions, with a concentration of 100 mg/m3, adhering to the DB33/310005-2021 standard[12]. - The company’s subsidiary, Gaobao Technology, reported a total wastewater discharge of 0.0876 tons for chemical oxygen demand, with a concentration of ≤100 mg/L, complying with GB 31573-2015[12]. - The company has implemented strict measures to ensure compliance with environmental standards, with no instances of exceeding discharge limits reported[12]. - The company is committed to environmental protection and has established a comprehensive environmental management system[5]. - The company’s subsidiaries also adhere to local environmental regulations and standards, ensuring compliance across all operations[6]. - The company continues to focus on sustainable practices and environmental responsibility in its business operations[5]. - The company has established wastewater treatment facilities with a design capacity of 150 m³/d and 500 m³/d in the East and West plants, respectively, utilizing advanced treatment processes[20]. - The West plant has added a new RTO exhaust treatment facility, ensuring compliance with environmental standards for exhaust emissions[21]. - The company has implemented a comprehensive solid waste management system, including hazardous waste storage facilities that meet regulatory requirements[22]. - The wastewater treatment system at the subsidiary, Gaobao Technology, has a design capacity of 600 m³/d, effectively treating both inorganic and organic wastewater[23]. - The company reported a total sulfur dioxide emission of 53.502 tons, which is below the regulatory limit of 400 mg/m³[19]. - The company achieved a chemical oxygen demand (COD) discharge of 0.878037 tons, adhering to the standard limit of 500 mg/L[19]. - The company has a total of 3 wastewater discharge points, ensuring effective management of wastewater across its facilities[19]. - The company has established a comprehensive environmental management system that includes rainwater and wastewater separation measures[23]. - The company’s hazardous waste storage facilities have been approved by environmental authorities, ensuring safe handling and disposal of hazardous materials[22]. - The company is committed to continuous improvement in environmental performance, with ongoing investments in new technologies and treatment processes[21]. - The company invested over ¥12.7187 million in environmental governance and protection during the reporting period[69]. - The company has implemented measures to reduce carbon emissions, including energy savings of 12,250 tons of standard coal annually after upgrading equipment[69]. - The company has established emergency response plans for environmental incidents, with plans submitted to local environmental protection authorities[61]. Financial Performance - The company reported a significant increase in revenue, achieving a total of 1.2 billion RMB for the year, representing a growth of 15% compared to the previous year[41]. - The company's operating revenue for 2023 was ¥1,343,528,068.38, a decrease of 16.16% compared to ¥1,602,399,044.70 in 2022[51]. - The net profit attributable to shareholders for 2023 was -¥179,132,650.63, representing a decline of 204.40% from ¥171,585,281.23 in 2022[51]. - The net cash flow from operating activities was -¥199,141,335.95 in 2023, a decrease of 388.99% compared to ¥68,909,932.53 in 2022[51]. - The basic earnings per share for 2023 was -¥0.5738, down 201.74% from ¥0.5640 in 2022[51]. - The total assets at the end of 2023 were ¥3,191,156,380.44, an increase of 6.11% from ¥3,007,334,202.48 at the end of 2022[51]. - The net assets attributable to shareholders decreased by 14.40% to ¥1,484,092,908.60 at the end of 2023 from ¥1,733,740,481.24 at the end of 2022[51]. - In Q1 2023, the operating revenue was ¥292,124,448.80, with a net profit of ¥27,400,008.09, while Q4 2023 saw revenue rise to ¥425,978,204.09 but a net loss of -¥150,375,731.25[55]. - The company reported a non-operating loss from the disposal of non-current assets amounting to approximately 23.78 million yuan in 2023, compared to 2.01 million yuan in 2022[78]. - Government subsidies recognized in the current period amounted to approximately 8.59 million yuan, an increase from 6.05 million yuan in 2022[78]. - The company achieved a net profit margin of 12%, reflecting improved operational performance and cost management[41]. - The company has a stable core management team with over ten years of industry experience, enabling quick adjustments to business strategies in response to market changes[135]. Market Expansion and Product Development - User data indicates that the company has expanded its customer base by 20%, reaching over 500,000 active users[41]. - The company has set a future outlook with a revenue target of 1.5 billion RMB for the next fiscal year, indicating a projected growth of 25%[41]. - New product development includes the introduction of a third-generation refrigerant, which is expected to capture a 10% market share within the first year of launch[49]. - The company has successfully completed the acquisition of a 51% stake in Jiangxi Aikesheng New Materials Co., expanding its business into hydrogen fluoride and fluorine new energy materials[49]. - The company plans to enhance its market expansion strategy by entering Southeast Asian markets, aiming for a 15% increase in international sales[49]. - Research and development investments have increased by 30%, focusing on high-performance polymer materials and fluorinated compounds[49]. - The company has established a partnership with a leading technology firm to co-develop advanced fluorine materials, expected to launch by Q3 2024[49]. - The company is focusing on the development of new energy electronic chemicals and advanced refrigerants, which will significantly enhance product technology content and added value[1]. - The company has established a complete fluorochemical industry chain, including raw materials like fluorite and hydrofluoric acid, enhancing its competitive advantage[1]. - The company is actively expanding its market presence and enhancing its marketing service system in both domestic and international markets[138]. - The company is committed to continuous technological innovation and investment in key projects to extend its industry chain[141]. Research and Development - Company has maintained R&D investment at approximately 4% of sales revenue in recent years, with an increase in absolute terms despite a slight decrease in percentage[126]. - A total of 13 invention patents and 1 utility model patent were applied for during the reporting period, with 4 invention patents and 1 foreign invention patent granted[126]. - Cumulative ownership of 48 national invention patents, 4 foreign invention patents, and 2 utility model patents by the end of the reporting period[126]. - Company is recognized as a key high-tech enterprise under the National Torch Program and has established a provincial-level research institute[126]. - Company has received 5 provincial-level technology achievement appraisals during the reporting period[126]. - Company has implemented ISO9001, ISO14001, and ISO45001 management system certifications to enhance product quality and labor efficiency[126]. - Advanced research and testing equipment, including German microreactors and liquid chromatography, has been introduced to improve product design capabilities[126]. - Company has an independent analysis and testing center equipped with comprehensive experimental facilities[126]. - The company has completed several key R&D projects aimed at optimizing production processes and enhancing product competitiveness[170]. - The company is actively developing new products and optimizing existing processes to enhance market competitiveness and increase sales revenue[170]. Operational Efficiency and Cost Management - The company has implemented a new strategy to improve operational efficiency, targeting a reduction in production costs by 5% over the next year[49]. - The energy procurement price accounts for over 30% of the total production cost, indicating significant cost management focus[93]. - The company has implemented a technology upgrade in its production process, improving resource utilization efficiency and reducing waste emissions[93]. - The company is focusing on enhancing supply chain management and improving operational efficiency to support strategic development in 2024[99]. - The company is implementing a digital transformation and smart manufacturing to improve operational efficiency and reduce costs[136]. - The company is actively monitoring raw material prices, which significantly impact operating costs and profit margins, and is taking measures to control procurement costs[104]. Challenges and Risks - The company is facing risks related to concentrated customer and sales regions, which could impact performance if market conditions change unfavorably[100]. - The main reasons for the performance decline were a drop in downstream market demand and intensified industry competition, with prices and volumes for agricultural and pharmaceutical products falling[138]. - The company experienced a significant reduction in the production of agricultural chemical products by 31.32%, primarily due to decreased orders and market conditions[160]. Financial Management and Investments - The company raised a total of RMB 441,849,999.80 through the issuance of 25,914,956 shares at an issue price of RMB 17.05 per share, with net proceeds amounting to RMB 433,107,367.75 after deducting fees[192]. - The company has fully utilized the raised funds, with a total of RMB 442,291,684.46 used by the end of the reporting period, leaving a balance of RMB 0.00[192]. - The fluorochemical series expansion project has achieved an investment progress of 102.16%, with a cumulative investment of RMB 29,815.33 million against a commitment of RMB 29,185 million[193]. - The annual production project of 5,000 tons of 4,4'-difluorobenzophenone has reached an investment progress of 101.95%, with a cumulative investment of RMB 10,195.15 million against a commitment of RMB 10,000 million[193]. - The company reported a total loss of RMB 2,329.47 million from the committed investment projects during the reporting period[193]. - The company has not engaged in any securities or derivative investments during the reporting period[188]. - The company has not sold any significant assets during the reporting period[196]. - There are no changes in the feasibility of the fundraising projects, and all projects are proceeding as planned[193]. - The company has not reported any issues or problems regarding the use and disclosure of raised funds[195]. - The company has not made any changes to the investment projects funded by the raised capital[195].